NCT01064479 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- From the first dose through 30 days after the last does of study medication, up to 5 years
- Other-event reporting threshold
- 5%
MedDRA v12
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Arm A (Combination Chemotherapy and Erlotinib Hydrochloride) | 21 / 60 | 56 / 60 | 37 / 60 |
| Arm B (Combination Chemotherapy and Placebo) | 46 / 59 | 55 / 59 | 53 / 59 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 59
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 59
- term
- Oral pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 59
- term
- Syncope
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 59
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Dysphagia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 59
- term
- Lung infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 59
- term
- Skin infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 59
- term
- Anemia
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 59
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 46
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 30
- num At Risk
- 59
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 13
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 59
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 38
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 27
- num At Risk
- 59
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 40
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 33
- num At Risk
- 59
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 59
- term
- Mucositis oral
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 35
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 12
- num At Risk
- 59
- term
- Rash maculo-papular
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 59
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 22
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 13
- num At Risk
- 59
- term
- Dry skin
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 59
- term
- Pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 59
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 31
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 59
- term
- Rash acneform
Complete source fields
- description
- MedDRA v12
- event Groups
- deaths Num Affected
- 37
- deaths Num At Risk
- 60
- description
- Patients receive docetaxel IV over 1 hour and cisplatin IV over 2 hours or carboplatin IV over 2 hours on day 1 and erlotinib hydrochloride PO daily on days 1-21. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression and unacceptable toxicity. Patients achieving complete response, partial response, or stable disease may continue erlotinib hydrochloride treatment.
- id
- EG000
- other Num Affected
- 56
- other Num At Risk
- 60
- serious Num Affected
- 21
- serious Num At Risk
- 60
- title
- Arm A (Combination Chemotherapy and Erlotinib Hydrochloride)
- deaths Num Affected
- 53
- deaths Num At Risk
- 59
- description
- Patients receive docetaxel and cisplatin or carboplatin as in Arm I and placebo PO daily on days 1-21. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression and unacceptable toxicity. Patients achieving complete response, partial response, or stable disease may continue placebo treatment.
- id
- EG001
- other Num Affected
- 55
- other Num At Risk
- 59
- serious Num Affected
- 46
- serious Num At Risk
- 59
- title
- Arm B (Combination Chemotherapy and Placebo)
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 59
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 46
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 30
- num At Risk
- 59
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 13
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 59
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 38
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 27
- num At Risk
- 59
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 40
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 33
- num At Risk
- 59
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 59
- term
- Mucositis oral
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 35
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 12
- num At Risk
- 59
- term
- Rash maculo-papular
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 59
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 22
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 13
- num At Risk
- 59
- term
- Dry skin
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 59
- term
- Pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 59
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 31
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 59
- term
- Rash acneform
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 59
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 59
- term
- Oral pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 59
- term
- Syncope
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 59
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Dysphagia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 59
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 59
- term
- Lung infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 59
- term
- Skin infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 60
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 59
- term
- Anemia
- time Frame
- From the first dose through 30 days after the last does of study medication, up to 5 years
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle